Status:
COMPLETED
Awake Proning in COVID-19 Patients With Hypoxemic Respiratory Failure
Lead Sponsor:
Columbia University
Conditions:
Oxygen Deficiency
Coronavirus Infection
Eligibility:
All Genders
18+ years
Brief Summary
The purpose of this study is to retrospectively review clinical data to determine whether awake proning improves oxygenation in spontaneously breathing patients with COVID-19 severe hypoxemic respirat...
Detailed Description
Critically ill patients with coronavirus disease 2019 (COVID-19) severely strained intensive care resources in New York in April 2020. The prone position improves oxygenation in intubated patients wit...
Eligibility Criteria
Inclusion
- Consecutive patients admitted to the Columbia University step-down unit from April 6, 2020.
- Laboratory confirmed COVID-19 infection with severe hypoxemic respiratory failure defined as respiratory rate ≥30 breaths/min and oxyhemoglobin saturation (SpO2) ≤93% while receiving supplemental oxygen 6 L/min via nasal cannula and 15 L/min via non-rebreather facemask.
Exclusion
- Altered mental status with inability to turn in bed without assistance
- Extreme respiratory distress requiring immediate intubation, or oxygen requirements less than specified in the inclusion criteria.
Key Trial Info
Start Date :
April 16 2020
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
March 6 2022
Estimated Enrollment :
29 Patients enrolled
Trial Details
Trial ID
NCT04408222
Start Date
April 16 2020
End Date
March 6 2022
Last Update
March 9 2022
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Columbia University Irving Medical Center
New York, New York, United States, 10032